Serial 88257056
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 26 Mar 2026)
What this means for you
Registered since 09 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88257056
- Registration number
- 6072361
- Mark type
- Design / logo
- Filed
- 10 Jan 2019
- Published for opposition
- 24 Mar 2020
- Registered
- 09 Jun 2020
- Attorney of record
- Kazuyo Morita
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical antipsychotic preparations; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of schizophrenia
Owner
- Hisamitsu Pharmaceutical Co., Inc., Tosu-shi, Saga, JP
- Hisamitsu Pharmaceutical Co., Inc., Tosu-shi, Saga, JP
- Hisamitsu Pharmaceutical Co., Inc., Tosu-shi, Saga, JP
Prosecution history
- 26 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 26 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Dec 2025 — TEAS SECTION 8 & 15 RECEIVED
- 09 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 24 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2020 — PUBLISHED FOR OPPOSITION
- 04 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Feb 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Feb 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Feb 2020 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 07 Jan 2020 — ASSIGNED TO EXAMINER
- 13 Nov 2019 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED